Introduction to Bispecific antibody manufacturer - Creative Biolabs

<p></p><hr id="null"><p>With the rapid development of recombinant protein technology, numerous BsAbs have emerged as therapeutic proteins. Creative Biolabs offers three approaches to develop BsAbs for customers: hybrid-hybridoma technology by the somatic fusion of two different hybridoma cell lines; chemical conjugation based on chemical crosslinkers; and genetic methods using recombinant DNA technology.</p><hr id="null"><p><a href="https://www.creative-biolabs.com/bsab/">https://www.creative-biolabs.com/bsab/</a></p><hr id="null"><p></p><p><a href="https://www.creative-biolabs.com/bsab/" <="" a=""></a></p><p><a href="https://www.creative-biolabs.com/bsab/" <="" a="">
<img src="https://www.biotechnologyforums.com/images/smilies/biggrin.gif" data-sceditor-emoticon="" alt="" title=""> </a></p><hr id="null"><p class="sceditor-nlf"><br></p>